 This is an open, parallel assignment low-dose, moderate-dose and high-dose, inpatient, sequential-group pharmacokinetics study of single oral administered and multiple oral administered to healthy Chinese male and female subjects at a single investigational site. All subjects are from the Chinese Han race. 